Can you beat the market with AstraZeneca plc, BAE Systems plc and ARM Holdings plc?

AstraZeneca plc (LON: AZN), BAE Systems plc (LON: BA) and Arm holdings plc (LON: ARM) could help turobocharge your portfolio’s returns.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Trying to build an equity portfolio from scratch is a daunting process. Where do you start? Well, there are three main ‘buckets’ of equities you can use to construct an all-weather portfolio that will generate steady returns over time. These three buckets are income, growth, and growth & income.

If you start at the beginning and buy one stock that falls into each one of these buckets, it’s difficult to go wrong, and you’ll have a solid portfolio backbone from which you can build out other equity positions. Here are three stocks that could be the perfect candidates.

Top income pick

When it comes to income, AstraZeneca (LSE: AZN) is a top pick. The drugs giant operates in a defensive industry and has always prioritised cash returns to investors. Indeed, dividends are so important to the company that Astra’s management compensation is linked to the company’s dividend payout. In other words, if shareholders don’t receive a set proportion of Astra’s income, then the company’s management has to take a pay cut.

For the past five years Astra’s shares have supported an average dividend yield of 4.9% and at present prices, the yield stands at 4.8%. The dividend payout is covered 1.5 times by earnings per share and Astra’s shares trade at a relatively attractive forward P/E of 14.6.

Rapid growth

BAE Systems (LSE: BA) provides the perfect blend of both growth and income. City analysts have pencilled-in a pre-tax profit of £1.5bn for 2016, and if BAE hits this target, the company will have seen its pre-tax profit grow by 270% over just four years. On a per share basis, analysts are expecting BAE to report earnings of 38.5p for the year ending 31 December 2016.

On this basis, the defence group’s shares trade at a forward P/E of 12.3. Analysts are currently expecting earnings per share growth of 7% for the year ending 31 December 2017.

What’s more, over the years BAE has built a reputation as an income champion. During the past five years the company’s shares have supported an average dividend yield of 5.1% and at current prices shares in BAE yield 4.3%. The payout is covered 1.9 times by earnings per share.

Unique growth

Astra and BAE both offer growth and income, but when it comes to a pure growth play, you can’t go wrong with Arm (LSE: ARM).

Despite concerns about the state of the semiconductor industry and flagging smartphone sales, at the end of April Arm reported a robust set of first-quarter numbers allaying worries about the company’s ability to grow in a maturing market. Revenues of $398m were up 14% year-on-year and 22% ahead in sterling terms, while pre-tax profits expanded 14% to $137.5m and earnings per share rose 15% to 8.2p, despite the fact that operating costs increased by a third. 

City analysts expect Arm’s earnings per share to grow by 43% to 34.6p overall this year, which puts the group on a forward P/E of 28.2 — its lowest valuation in five years. Arm’s shares only offer a token dividend yield of 1%.

Rupert Hargreaves has no position in any shares mentioned. The Motley Fool UK has recommended ARM Holdings and AstraZeneca. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Trader on video call from his home office
Investing Articles

Down 19%! Here’s why Barclays shares look a serious bargain to me right now

Barclays shares have slumped recently, but a big gap between price and fair value has opened, offering nimble long-term investors…

Read more »

CEO Mark Zuckerberg at F8 2019 event
Investing Articles

Why Meta Platforms shares fell 12.5% in March

Historically, investors have done well by buying Meta Platforms shares when the price has fallen. But is the latest legal…

Read more »

Arrow symbol glowing amid black arrow symbols on black background.
Investing Articles

£20,000 invested in BAE Systems shares 4 years ago is now worth…

BAE Systems' shares have soared since 2022, yet rising NATO budgets are just starting to feed through, so the real…

Read more »

This way, That way, The other way - pointing in different directions
Investing For Beginners

Aviva shares fell 12% in March! Here’s my outlook from here

Jon Smith explains why Aviva shares underperformed last month, but paints an upbeat picture for the stock when looking further…

Read more »

Passive income text with pin graph chart on business table
Investing Articles

A 6.3% forecast yield! 1 bargain-basement FTSE passive income gem to buy today?  

This FTSE 100 passive income star has delivered consistently high dividends, with analysts forecasting more to come, and it looks…

Read more »

British coins and bank notes scattered on a surface
Investing Articles

£100 invested in a Stocks and Shares ISA today could be worth…

A Stocks and Shares ISA is a proven way of building wealth. But how much could a smaller stake of…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

April opportunities: 2 heavily-discounted stocks to consider buying

Are under-the-radar growth stocks the best place to look for potential stocks to buy as investors look for certainty in…

Read more »

Workers at Whiting refinery, US
Value Shares

Why the BP share price *finally* surged 24.5% in March

Long-term owners of BP stock have had a frustrating few years, but is the share price rising 24.5% in March…

Read more »